BioCentury
ARTICLE | Financial News

Can-Fite completes direct public offering

January 20, 2017 10:12 PM UTC

Cancer and inflammatory disease company Can-Fite BioPharma Ltd. (Tel Aviv:CFBI; NYSE-M:CANF) raised $5 million through the sale of 2.5 million ADSs at $2 in a registered direct offering with institut...

BCIQ Company Profiles

Can-Fite BioPharma Ltd.